CTLA4 overexpressing adipose tissue-derived mesenchymal stem cell therapy in a dog with steroid-refractory pemphigus foliaceus

Sei Myoung Han, Hyun Tae Kim, Kun Woo Kim, Kee Ok Jeon, Kyoung Won Seo, Eun Wha Choi, Hwa Young Youn

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Background: Canine pemphigus foliaceus is an autoimmune antibody-mediated skin disease characterized by acantholysis. The objective of this case report is to present the successful management of steroid refractory pemphigus foliaceus with cytotoxic T-lymphocyte antigen 4 (CTLA4)-overexpressing adipose tissue mesenchymal stem cells (ATMSCs). Case presentation: A 10-year-old, 12.3-kg, castrated male Shih Tzu presented with severe pruritus and anorexia. The diagnosis of pemphigus foliaceus was made based on its history, physical examination, and histopathology results of a skin biopsy. Treatment with prednisolone and combination therapy of other immunosuppressive drugs had failed; therefore, immunosuppressive gene, CTLA4 overexpressing ATMSCs (CTLA4-ATMSCs) and/or naive ATMSCs administration was performed with the consent of the owner. ATMSCs were administered 21 times over a period of 20 months with intervals of 2 to 8 week. Prednisolone was gradually tapered concurrently and no relapse of the clinical signs was observed. After the termination of CTLA4-ATMSCs and/or naive ATMSCs treatment, the skin lesions had improved and could be managed with a low dose of prednisolone for 12 months. Conclusion: CTLA4-ATMSCs or naive ATMSCs transplantation may be beneficial as adjunctive therapy to initiate and maintain the remission of skin lesions caused by pemphigus foliaceus in veterinary medicine.

Original languageEnglish (US)
Article number49
JournalBMC Veterinary Research
Volume11
Issue number1
DOIs
StatePublished - Mar 6 2015
Externally publishedYes

Fingerprint

pemphigus (skin disease)
CTLA-4 Antigen
lymphocyte antigens
therapy dogs
cytotoxic T-lymphocytes
Pemphigus
Cell- and Tissue-Based Therapy
Mesenchymal Stromal Cells
adipose tissue
steroids
stem cells
Adipose Tissue
Steroids
Dogs
prednisolone
Prednisolone
immunosuppressive agents
skin lesions
Immunosuppressive Agents
Skin

Keywords

  • Autoimmune disease
  • CTLA4
  • Dog
  • Mesenchymal stem cell
  • Pemphigus foliaceus

ASJC Scopus subject areas

  • veterinary(all)

Cite this

CTLA4 overexpressing adipose tissue-derived mesenchymal stem cell therapy in a dog with steroid-refractory pemphigus foliaceus. / Han, Sei Myoung; Kim, Hyun Tae; Kim, Kun Woo; Jeon, Kee Ok; Seo, Kyoung Won; Choi, Eun Wha; Youn, Hwa Young.

In: BMC Veterinary Research, Vol. 11, No. 1, 49, 06.03.2015.

Research output: Contribution to journalArticle

Han, Sei Myoung ; Kim, Hyun Tae ; Kim, Kun Woo ; Jeon, Kee Ok ; Seo, Kyoung Won ; Choi, Eun Wha ; Youn, Hwa Young. / CTLA4 overexpressing adipose tissue-derived mesenchymal stem cell therapy in a dog with steroid-refractory pemphigus foliaceus. In: BMC Veterinary Research. 2015 ; Vol. 11, No. 1.
@article{2c5ba4b23f244aba97753bc32b59b71e,
title = "CTLA4 overexpressing adipose tissue-derived mesenchymal stem cell therapy in a dog with steroid-refractory pemphigus foliaceus",
abstract = "Background: Canine pemphigus foliaceus is an autoimmune antibody-mediated skin disease characterized by acantholysis. The objective of this case report is to present the successful management of steroid refractory pemphigus foliaceus with cytotoxic T-lymphocyte antigen 4 (CTLA4)-overexpressing adipose tissue mesenchymal stem cells (ATMSCs). Case presentation: A 10-year-old, 12.3-kg, castrated male Shih Tzu presented with severe pruritus and anorexia. The diagnosis of pemphigus foliaceus was made based on its history, physical examination, and histopathology results of a skin biopsy. Treatment with prednisolone and combination therapy of other immunosuppressive drugs had failed; therefore, immunosuppressive gene, CTLA4 overexpressing ATMSCs (CTLA4-ATMSCs) and/or naive ATMSCs administration was performed with the consent of the owner. ATMSCs were administered 21 times over a period of 20 months with intervals of 2 to 8 week. Prednisolone was gradually tapered concurrently and no relapse of the clinical signs was observed. After the termination of CTLA4-ATMSCs and/or naive ATMSCs treatment, the skin lesions had improved and could be managed with a low dose of prednisolone for 12 months. Conclusion: CTLA4-ATMSCs or naive ATMSCs transplantation may be beneficial as adjunctive therapy to initiate and maintain the remission of skin lesions caused by pemphigus foliaceus in veterinary medicine.",
keywords = "Autoimmune disease, CTLA4, Dog, Mesenchymal stem cell, Pemphigus foliaceus",
author = "Han, {Sei Myoung} and Kim, {Hyun Tae} and Kim, {Kun Woo} and Jeon, {Kee Ok} and Seo, {Kyoung Won} and Choi, {Eun Wha} and Youn, {Hwa Young}",
year = "2015",
month = "3",
day = "6",
doi = "10.1186/s12917-015-0371-3",
language = "English (US)",
volume = "11",
journal = "BMC Veterinary Research",
issn = "1746-6148",
publisher = "BioMed Central",
number = "1",

}

TY - JOUR

T1 - CTLA4 overexpressing adipose tissue-derived mesenchymal stem cell therapy in a dog with steroid-refractory pemphigus foliaceus

AU - Han, Sei Myoung

AU - Kim, Hyun Tae

AU - Kim, Kun Woo

AU - Jeon, Kee Ok

AU - Seo, Kyoung Won

AU - Choi, Eun Wha

AU - Youn, Hwa Young

PY - 2015/3/6

Y1 - 2015/3/6

N2 - Background: Canine pemphigus foliaceus is an autoimmune antibody-mediated skin disease characterized by acantholysis. The objective of this case report is to present the successful management of steroid refractory pemphigus foliaceus with cytotoxic T-lymphocyte antigen 4 (CTLA4)-overexpressing adipose tissue mesenchymal stem cells (ATMSCs). Case presentation: A 10-year-old, 12.3-kg, castrated male Shih Tzu presented with severe pruritus and anorexia. The diagnosis of pemphigus foliaceus was made based on its history, physical examination, and histopathology results of a skin biopsy. Treatment with prednisolone and combination therapy of other immunosuppressive drugs had failed; therefore, immunosuppressive gene, CTLA4 overexpressing ATMSCs (CTLA4-ATMSCs) and/or naive ATMSCs administration was performed with the consent of the owner. ATMSCs were administered 21 times over a period of 20 months with intervals of 2 to 8 week. Prednisolone was gradually tapered concurrently and no relapse of the clinical signs was observed. After the termination of CTLA4-ATMSCs and/or naive ATMSCs treatment, the skin lesions had improved and could be managed with a low dose of prednisolone for 12 months. Conclusion: CTLA4-ATMSCs or naive ATMSCs transplantation may be beneficial as adjunctive therapy to initiate and maintain the remission of skin lesions caused by pemphigus foliaceus in veterinary medicine.

AB - Background: Canine pemphigus foliaceus is an autoimmune antibody-mediated skin disease characterized by acantholysis. The objective of this case report is to present the successful management of steroid refractory pemphigus foliaceus with cytotoxic T-lymphocyte antigen 4 (CTLA4)-overexpressing adipose tissue mesenchymal stem cells (ATMSCs). Case presentation: A 10-year-old, 12.3-kg, castrated male Shih Tzu presented with severe pruritus and anorexia. The diagnosis of pemphigus foliaceus was made based on its history, physical examination, and histopathology results of a skin biopsy. Treatment with prednisolone and combination therapy of other immunosuppressive drugs had failed; therefore, immunosuppressive gene, CTLA4 overexpressing ATMSCs (CTLA4-ATMSCs) and/or naive ATMSCs administration was performed with the consent of the owner. ATMSCs were administered 21 times over a period of 20 months with intervals of 2 to 8 week. Prednisolone was gradually tapered concurrently and no relapse of the clinical signs was observed. After the termination of CTLA4-ATMSCs and/or naive ATMSCs treatment, the skin lesions had improved and could be managed with a low dose of prednisolone for 12 months. Conclusion: CTLA4-ATMSCs or naive ATMSCs transplantation may be beneficial as adjunctive therapy to initiate and maintain the remission of skin lesions caused by pemphigus foliaceus in veterinary medicine.

KW - Autoimmune disease

KW - CTLA4

KW - Dog

KW - Mesenchymal stem cell

KW - Pemphigus foliaceus

UR - http://www.scopus.com/inward/record.url?scp=84928638135&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928638135&partnerID=8YFLogxK

U2 - 10.1186/s12917-015-0371-3

DO - 10.1186/s12917-015-0371-3

M3 - Article

C2 - 25889154

AN - SCOPUS:84928638135

VL - 11

JO - BMC Veterinary Research

JF - BMC Veterinary Research

SN - 1746-6148

IS - 1

M1 - 49

ER -